Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bossier City, LA
NPI
1861437543
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2449 Hospital Dr, Suite 400
Bossier City, LA, 71111
Phone (318) 212-7902
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,217 services
Medicare patients, 2024
476
Average age 73
Drug cost, 2024
$1.0M
2,961 prescriptions
Company payments, 2025
$42K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura Kimball-Ravari was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 472 times for 380 patients. In total Laura Kimball-Ravari billed 1,217 services in 15 codes, and Medicare paid $70K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 472 | 380 | $12.15 | $5,735 |
| 99214 Office E&M - Established | Office | 470 | 383 | $83.38 | $39K |
| 99215 Office E&M - Established | Office | 95 | 67 | $123.28 | $12K |
| 95251 Test - Miscellaneous | Office | 41 | 25 | $23.65 | $970 |
| 10005 Other Organ Systems | Office | 36 | 35 | $97.31 | $3,503 |
| 99443 Telephone Services | Office | 28 | 27 | $79.76 | $2,233 |
| 99205 Office E&M - New | Office | 21 | 21 | $159.33 | $3,346 |
| 99204 Office E&M - New | Office | 15 | 15 | $106.23 | $1,594 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 15 | 14 | $24.32 | $365 |
| 10006 Other Organ Systems | Office | 12 | 12 | $44.69 | $536 |
By year: 2022 $57K for 960 services; 2023 $61K for 788 services; 2024 $70K for 1,217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura Kimball-Ravari prescribed most often to Medicare patients was Levothyroxine Sodium, with 734 prescriptions and refills. In total Laura Kimball-Ravari wrote 2,961 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 734 | 1,542 | 194 | $5,225 |
| Synthroid Levothyroxine Sodium | 595 | 1,241 | 134 | $53K |
| Liothyronine Sodium Generic | 133 | 273 | 36 | $3,963 |
| Metformin Hcl Er Metformin Hcl | 102 | 201 | 28 | $946 |
| Methimazole Generic | 88 | 143 | 25 | $563 |
| Ozempic Semaglutide | 80 | 100 | 17 | $93K |
| Mounjaro Tirzepatide | 78 | 91 | 16 | $90K |
| Hydrocortisone Generic | 59 | 74 | Under 11 | $3,017 |
| Tirosint Levothyroxine Sodium | 55 | 73 | Under 11 | $9,330 |
| Cabergoline Generic | 50 | 74 | Under 11 | $1,795 |
| Armour Thyroid Thyroid,pork | 49 | 78 | Under 11 | $2,960 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 41 | 98 | 17 | $28K |
| Jardiance Empagliflozin | 38 | 68 | 12 | $39K |
| Vascepa Icosapent Ethyl | 35 | 40 | Under 11 | $14K |
| Novolog Insulin Aspart | 29 | 48 | Under 11 | $7,953 |
Brand drugs: 1,767 claims; generic drugs: 1,047 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura Kimball-Ravari $42K ($42K in general payments such as food, travel and fees) from 31 companies. The largest payer was Novo Nordisk Inc with $34K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.